CNBC
4 days ago
Johnson & Johnson sues Biden administration over Medicare drug price negotiations
Merck, Bristol Myers Squibb, the U.S. Chamber of Commerce and PhRMA filed separate lawsuits against the provision last month.
Latest News
Kenvue shares fall even as J&J spinoff beats estimates in first quarterly earnings since IPO
2 days ago
Johnson & Johnson investors can soon swap their shares for Kenvue stock — here's what you need to know
2 days ago
Warning labels in the U.S. seem to be everywhere. Here's why they may be pointless
4 weeks ago
Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer
4 weeks ago
Jim Cramer talks about his 'favorite stock,' telling investors to buy some as we did last week
1 week ago